Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Han

Showing results (91-100 of 102) with videos related to

Pageof 11
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|December 16, 2020
On the use of simulation in robotics: Opportunities, challenges, and suggestions for moving forwardHeeSun Choi, Cindy Crump, Christian Duriez, et al.
Substance Use & Misuse|December 20, 2017
A Systematic, Intensive Statistical Investigation of Data from the Comprehensive Analysis of Reported Drugs (CARD) for Compliance and Illicit Opioid Abstinence in Substance Addiction Treatment with Buprenorphine/naloxoneKenneth Blum, David Han, Edward J Modestino, et al.
Journal of Addiction Research & Therapy|November 26, 2013
Withdrawal from Buprenorphine/Naloxone and Maintenance with a Natural Dopaminergic Agonist: A Cautionary NoteKenneth Blum, Marlene Oscar-Berman, John Femino, et al.
Journal of Addiction Research & Therapy|November 26, 2013
Declinol, a Complex Containing Kudzu, Bitter Herbs (Gentian, Tangerine Peel) and Bupleurum, Significantly Reduced Alcohol Use Disorders Identification Test (AUDIT) Scores in Moderate to Heavy Drinkers: A Pilot StudySteven Kushner, David Han, Marlene Oscar-Berman, et al.
Journal of Personalized Medicine|September 23, 2022
Statistical Validation of Risk Alleles in Genetic Addiction Risk Severity (GARS) Test: Early Identification of Risk for Alcohol Use Disorder (AUD) in 74,566 Case-Control SubjectsKenneth Blum, David Han, Ashim Gupta, et al.
Journal of Personalized Medicine|December 29, 2022
Genetic Addiction Risk and Psychological Profiling Analyses for "Preaddiction" Severity IndexKenneth Blum, David Han, Abdalla Bowirrat, et al.
Science Translational Medicine|January 8, 2025
Hypoxia-inducible factor 2 regulates alveolar regeneration after repetitive injury in three-dimensional cellular and in vivo modelsA Scott McCall, Sergey Gutor, Hari Tanjore, et al.
Journal of Addiction Research & Therapy|August 9, 2013
Neurogenetics and Nutrigenomics of Neuro-Nutrient Therapy for Reward Deficiency Syndrome (RDS): Clinical Ramifications as a Function of Molecular Neurobiological MechanismsKenneth Blum, Marlene Oscar-Berman, Elizabeth Stuller, et al.
Vaccine|September 30, 2023
Evaluation of a stabilized RSV pre-fusion F mRNA vaccine: Preclinical studies and Phase 1 clinical testing in healthy adultsJesse Nussbaum, Xin Cao, Radha A Railkar, et al.
Science Translational Medicine|April 22, 2021
Blocking endothelial lipase with monoclonal antibody MEDI5884 durably increases high density lipoprotein in nonhuman primates and in a phase 1 trialJohn E Le Lay, Qun Du, Minal B Mehta, et al.
Pageof 11

Showing results (91-100 of 102) with videos related to

Sort By:
Pageof 11
Proceedings of the National Academy of Sciences of the United States of America|December 16, 2020
On the use of simulation in robotics: Opportunities, challenges, and suggestions for moving forwardHeeSun Choi, Cindy Crump, Christian Duriez, et al.
Substance Use & Misuse|December 20, 2017
A Systematic, Intensive Statistical Investigation of Data from the Comprehensive Analysis of Reported Drugs (CARD) for Compliance and Illicit Opioid Abstinence in Substance Addiction Treatment with Buprenorphine/naloxoneKenneth Blum, David Han, Edward J Modestino, et al.
Journal of Addiction Research & Therapy|November 26, 2013
Withdrawal from Buprenorphine/Naloxone and Maintenance with a Natural Dopaminergic Agonist: A Cautionary NoteKenneth Blum, Marlene Oscar-Berman, John Femino, et al.
Journal of Addiction Research & Therapy|November 26, 2013
Declinol, a Complex Containing Kudzu, Bitter Herbs (Gentian, Tangerine Peel) and Bupleurum, Significantly Reduced Alcohol Use Disorders Identification Test (AUDIT) Scores in Moderate to Heavy Drinkers: A Pilot StudySteven Kushner, David Han, Marlene Oscar-Berman, et al.
Journal of Personalized Medicine|September 23, 2022
Statistical Validation of Risk Alleles in Genetic Addiction Risk Severity (GARS) Test: Early Identification of Risk for Alcohol Use Disorder (AUD) in 74,566 Case-Control SubjectsKenneth Blum, David Han, Ashim Gupta, et al.
Journal of Personalized Medicine|December 29, 2022
Genetic Addiction Risk and Psychological Profiling Analyses for "Preaddiction" Severity IndexKenneth Blum, David Han, Abdalla Bowirrat, et al.
Science Translational Medicine|January 8, 2025
Hypoxia-inducible factor 2 regulates alveolar regeneration after repetitive injury in three-dimensional cellular and in vivo modelsA Scott McCall, Sergey Gutor, Hari Tanjore, et al.
Journal of Addiction Research & Therapy|August 9, 2013
Neurogenetics and Nutrigenomics of Neuro-Nutrient Therapy for Reward Deficiency Syndrome (RDS): Clinical Ramifications as a Function of Molecular Neurobiological MechanismsKenneth Blum, Marlene Oscar-Berman, Elizabeth Stuller, et al.
Vaccine|September 30, 2023
Evaluation of a stabilized RSV pre-fusion F mRNA vaccine: Preclinical studies and Phase 1 clinical testing in healthy adultsJesse Nussbaum, Xin Cao, Radha A Railkar, et al.
Science Translational Medicine|April 22, 2021
Blocking endothelial lipase with monoclonal antibody MEDI5884 durably increases high density lipoprotein in nonhuman primates and in a phase 1 trialJohn E Le Lay, Qun Du, Minal B Mehta, et al.
Pageof 11